However, conflicting findings suggest that selective ablation of METTL3 in myeloid cells remodels the TME, increasing M1/M2‐like tumour‐associated macrophage and regulatory T (Treg) cell infiltration.143. The gene discussed is METTL3; the disease is neoplasm.